浙江医药 (600216)

Zhejiang Medicine Co., Ltd.

ASH

Tags

Nicotinamide Mononucleotide (NMN) ConceptSSE 380 IndexSpecial Purpose LoansLow Price-to-Earnings RatioEnergy StorageInnovative DrugsChemical PharmaceuticalsMedical Aesthetics ConceptPharmaceutical ManufacturingPharmaceuticals and HealthcareSynthetic BiologyPlanned Reduction of HoldingsHigh-Performing StocksVitaminsHepatitis ConceptEquity IncentivesFree Cash FlowMargin Trading and Securities LendingAssisted ReproductionSodium Batteries

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 96163.78
  • Circulating A-Shares(W): 96163.35
  • Earnings Per Share(RMB): 0.9700
  • Net Assets Per Share(RMB): 11.4959
  • Operating Revenue(W RMB): 669529.79
  • Total Profit(W RMB): 104630.66
  • **Net Profit Attributable to Parent(W RMB) **: 93314.79
  • Net Profit Growth Rate(%): 9.83
  • Weighted Return on Equity(%): 8.4900
  • Operating Cash Flow Per Share(RMB): 1.5480
  • Undistributed Profit Per Share(RMB): 6.7740
  • Capital Reserve Per Share(RMB): 2.0712

2. Main Business

The main business covers:

  • Life Nutrition Products
  • Pharmaceutical Manufacturing Products
  • Pharmaceutical Commerce

3. Company Basic Information

  • Company Name: Zhejiang Medicine Co., Ltd.
  • Listing Date: 1999-10-21
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 168, Zhiyuanzhong Avenue, Binhai New City, Shaoxing City, Zhejiang Province
  • Website: https://www.zmc.top
  • Company Profile: The company was established on May 16, 1997, through the merger of the former Zhejiang Xinchang Pharmaceutical Co., Ltd., Zhejiang Xianju Pharmaceutical Group Co., Ltd., and Zhejiang Pharmaceutical Co., Ltd. After the merger, the company's total net assets were 265.6651 million yuan, which was converted into 172.8 million shares at a ratio of 65.044%. After the company issued 58 million public shares (including 5.8 million shares allocated to funds) on August 11, 1999, the company's total share capital reached 230.8 million shares. Its 52.2 million public shares were listed on the Shanghai Stock Exchange on October 21, 1999.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Xinchang County Changxin Investment Development Co., Ltd. General Legal Person 20819.24 21.65
2 SDIC High-Tech Investment Co., Ltd. General Legal Person 15012.76 15.61
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 4664.55 4.85
4 Xianju County Industrial Investment Development Group Co., Ltd. General Legal Person 1724.46 1.79
5 Yinhua CSI Innovative Drug Industry ETF Fund 654.21 0.68
6 Southern CSI 1000 ETF Fund 615.88 0.64
7 Nuoan Dingli Mixed Securities Investment Fund Class A Fund 10.98 0.01

5. Concept Sectors

  • Vitamins
  • Medical Aesthetics Concept
  • Energy Storage
  • NMN Concept
  • Sodium Battery
  • Assisted Reproduction
  • Hepatitis Concept
  • Innovative Drugs
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Equity Incentives
  • Low P/E Ratio
  • Blue-chip Stocks
  • Proposed Reduction
  • Special Loans
  • Free Cash Flow
  • SSE 380

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information